Table: Cosmo Bio -2022 group results

Cosmo Bio

14/02/2023 06:00

Feb 14 (Reuters)- 
          Cosmo Bio Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Dec 31, 2022    Dec 31, 2021   Dec 31, 2023     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           9.55            9.23           9.80          5.20    
               (+3.5 pct)      (+14.1 pct)    (+2.6 pct)    (+1.7 pct) 
  Operating      816 mln          1.05          600 mln      440 mln   
               (-22.2 pct)     (+39.4 pct)    (-26.5 pct)  (-29.7 pct) 
  Recurring      790 mln          1.10          660 mln      490 mln   
               (-28.1 pct)     (+34.5 pct)    (-16.5 pct)  (-21.0 pct) 
  Net
  Net            517 mln         737 mln        450 mln      330 mln   
               (-29.8 pct)     (+9.4 pct)     (-13.0 pct)  (-19.0 pct) 
  EPS           89.13 yen      126.94 yen      77.41 yen    56.77 yen  
  Ann Div       36.00 yen       36.00 yen      30.00 yen               
  -Q2 Div       16.00 yen       12.00 yen      14.00 yen               
  -Q4 Div       20.00 yen       24.00 yen      16.00 yen               
  
  NOTE - Cosmo Bio Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3386.T